Evidence map›Paper›PMID 38334891›Full record

ArticleEndocrine2024

A rare case report of reversible glucose counterregulation in an insulinoma patient with type 2 diabetes.

Jian-Hui Teng, Jun-Pei Hu, Xia Wang, Chi Zhang, Jing Chen

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jian-Hui TengHunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 41005, Hunan Province, China.
Jun-Pei HuHunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 41005, Hunan Province, China.
Xia WangDepartment of Endocrinology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 41005, Hunan Province, China.
Chi ZhangDepartment of Endocrinology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 41005, Hunan Province, China.
Jing ChenDepartment of Endocrinology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 41005, Hunan Province, China. chenjingnfmk@163.com.ORCID 0009-0007-4795-0141
Hunan Normal University · CN

Funding

Health Committee of Hunan Province 20201755
6 · The paper itself

Abstract

contextInsulinoma is a neuroendocrine tumor derived from pancreatic β -cells whose clinical manifestation is recurrent hypoglycemia. Insulinoma in a patient with preexisting diabetes is extraordinarily rare, and the unmasking of type 2 diabetes (T CASE REPORT: This article reports a 49-year-old male patient with insulinoma that masked the diagnosis of T

conclusionsThe diagnosis of T

Indexed as

Diabetes Mellitus, Type 2InsulinomaPancreatic NeoplasmsBlood GlucoseHumansHydrocortisoneHypoglycemiaMaleMiddle AgedBlood GlucoseHydrocortisoneAdrenocortical insufficiencyCase reportGlucose counterregulationInsulinomaType 2 diabetes (T2DM)

Identifiers

PMID38334891
PMCPMC11208232
OpenAlexW4391680291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.